Search research articles
Contact Us
Filters
Showing results (251-260 of 316) with videos related to
Page
of 32
Sort By:
Cytokine
|
September 1, 1996
Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood
D Clarke, P W Johnson, R E Banks, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 8, 2009
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirus
Robin J Prestwich, Fiona Errington, Lynette P Steele, et al.
Proteomics
|
May 7, 2011
A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses
Matthew P Welberry Smith, Steven L Wood, Alexandre Zougman, et al.
Gene Therapy
|
March 14, 2009
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E J Ilett, R J Prestwich, T Kottke, et al.
Endocrine-Related Cancer
|
January 14, 2014
Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line
Faith Nutter, Ingunn Holen, Hannah K Brown, et al.
Metabolism: Clinical and Experimental
|
October 22, 1998
Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study
B V Howard, E J Mayer-Davis, D Goff, et al.
BJU International
|
November 15, 2008
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma
Robin J Prestwich, Karen J Scott, Joanne Brown, et al.
Cancer Immunology Research
|
January 12, 2017
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Takuro Noguchi, Jeffrey P Ward, Matthew M Gubin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2006
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma
Chooi P Lee, Poulam M Patel, Peter J Selby, et al.
BMC Cancer
|
December 18, 2012
The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renal cancer
Fiona J Collinson, Walter M Gregory, Chris McCabe, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 316) with videos related to
Sort By:
Page
of 32
Cytokine
|
September 1, 1996
Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood
D Clarke, P W Johnson, R E Banks, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 8, 2009
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirus
Robin J Prestwich, Fiona Errington, Lynette P Steele, et al.
Proteomics
|
May 7, 2011
A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses
Matthew P Welberry Smith, Steven L Wood, Alexandre Zougman, et al.
Gene Therapy
|
March 14, 2009
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E J Ilett, R J Prestwich, T Kottke, et al.
Endocrine-Related Cancer
|
January 14, 2014
Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line
Faith Nutter, Ingunn Holen, Hannah K Brown, et al.
Metabolism: Clinical and Experimental
|
October 22, 1998
Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study
B V Howard, E J Mayer-Davis, D Goff, et al.
BJU International
|
November 15, 2008
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma
Robin J Prestwich, Karen J Scott, Joanne Brown, et al.
Cancer Immunology Research
|
January 12, 2017
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Takuro Noguchi, Jeffrey P Ward, Matthew M Gubin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2006
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma
Chooi P Lee, Poulam M Patel, Peter J Selby, et al.
BMC Cancer
|
December 18, 2012
The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renal cancer
Fiona J Collinson, Walter M Gregory, Chris McCabe, et al.
Page
of 32